Elder Medication Optimizer AI
Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
AI assistant for clinicians and caregivers that finds safe medication alternatives when drugs are in shortage, specifically optimized for elderly patients on multiple medications.
Kill Reason
Epic and Oracle Health already embed clinical decision support and drug interaction checking into their pharmacy modules, and hospital formulary systems manage shortage substitutions through established clinical pharmacist workflows. The FDA's clinical decision software classification framework creates meaningful compliance burden for any AI tool that makes active medication substitution recommendations — a single adverse event triggers liability exposure that would shut down a startup immediately.
What do you think?
Related ideas you can explore free:
killed: Consumer spectroscopy hardware at the $50–100 price point cannot reliably detect food contaminants — this is a documented technical limitation that already killed SCiO ($23M raised), Tellspec, and Consumer Physics before them. At the accuracy levels achievable with phone-attachment optical sensors, false-positive rates would be high enough to make the product dangerous as a safety device and useless as a consumer gadget. FDA regulation of food safety testing devices would require clinical validation the physics cannot support.
killed: The consumer water filtration and testing market is dominated by Brita, ZeroWater, and Culligan, all of which are adding PFAS-reduction claims to their products. The personalized AI layer doesn't create a defensible moat — any filter company can add an app, and the actual testing hardware for lab-grade PFAS detection remains expensive and regulated.
killed: Distributed AI inference across local networks is an active open-source development area — Petals, ExLlamaV2, and llama.cpp all address this problem, and NVIDIA and AMD are solving the same constraint with hardware. The business model is unclear: who pays for software to pool RAM when cloud inference is cheaper and simpler for most use cases?